Efavirenz Dose Reduction Is Safe in Patients With High Plasma Concentrations and May Prevent Efavirenz Discontinuations
SourceJAIDS : Journal of Acquired Immune Deficiency Syndromes, 52, 2, (2009), pp. 240-245
Article / Letter to editor
Display more detailsDisplay less details
JAIDS : Journal of Acquired Immune Deficiency Syndromes
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.